Malaria is still an important health problem worldwide, particularly in Sub-Saharan Africa. In Turkey, the most common type of malaria is Plasmodium vivax, and endemic regions are South-Eastern Anatolia and Çukurova. Due to globalization and tourism, travel-associated infection due to P. falciparum is also seen more frequently in Turkey. P. falciparum malaria can be highly fatal despite optimal antimalarial treatment. We present a case of falciparum malaria in a Turkish radiologist who went to Africa for occupational reasons and come back with malaria accompanied by uveitis, hyperglycemia, and purpuric rash.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5152/tpd.2014.3406 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ocular Manifestations of IBD: Pathophysiology, Epidemiology, and Iatrogenic Associations of Emerging Treatment Strategies.
Biomedicines
December 2024
Department of Gastroenterology, The Royal Wolverhampton NHS Trust, Wolverhampton WV10 0QP, UK.
Inflammatory bowel disease (IBD) is a complex, multisystemic disease and is associated with ocular pathology in 4-12% of patients. In general, ocular disease affects Crohn's patients more frequently than those with ulcerative colitis. Episcleritis and uveitis are the most common presentations, with episcleritis often correlating with IBD flares, whereas uveitis presents independently of IBD activity and, in some cases, may even alert clinicians to a new diagnosis of IBD.
View Article and Find Full Text PDFEfficacy and tolerability of subcutaneous repository corticotropin injection in refractory ocular inflammatory diseases.
J Ophthalmic Inflamm Infect
October 2024
Department of Ophthalmology, Byers Eye Institute, Stanford University, 2452 Watson Court Suite 200, 94303, Palo Alto, CA, USA.
Background: Repository corticotropin injection (RCI) has been suggested to exert immunomodulatory and anti-inflammatory effects in ocular inflammation. The index retrospective study aimed to evaluate the efficacy and tolerability of subcutaneous RCI in patients with active scleritis or uveitis.
Main Body: Medical records of patients who were diagnosed with different types of active scleritis or uveitis and received RCI for more than six months at a tertiary eye center were reviewed.
Response to Acthar Gel in sarcoidosis uveitis: A prospective open label study.
Respir Med
November 2023
Department of Pulmonary Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH, USA.
Purpose: To investigate the response to Acthar Gel® in patients with moderate to severe sarcoidosis uveitis.
Methods: This is a prospective open-label study that enrolled patients with moderate to severe sarcoidosis uveitis to receive 80 units daily of Acthar Gel for ten days followed by maintenance treatment with 80 units twice weekly. The primary outcome was the proportion of patients meeting at least one of the following variables 1) improved visual acuity, 2) resolution of intraocular inflammation, 3) ability to taper ocular or oral steroids by at least 50% or 4) reduction of cystoid macular edema, with no worsening of any single measure and no need for additional sarcoidosis therapies at 24 weeks.
TACROLIMUS FOR IMMUNOSUPPRESSION IN PATIENTS WITH NONINFECTIOUS INTERMEDIATE, POSTERIOR, OR PANUVEITIDES.
Retina
September 2023
Department of Ophthalmology, the New York Eye and Ear Infirmary of Mount Sinai, the Icahn School of Medicine at Mount Sinai, New York, New York.
Purpose: To evaluate the effectiveness of tacrolimus in patients with noninfectious intermediate, posterior, or panuveitis needing a two-immunosuppressive-agent regimen.
Methods: Design: Retrospective cohort study. Setting: Two tertiary-care uveitis practices at academic medical centers.
Article Synopsis
- Vogt-Koyanagi-Harada (VKH) disease is an autoimmune condition that impacts tissues like the eyes and skin, and this report highlights a rare case of photoreceptor layer regeneration in a child after total loss.
- A 12-year-old boy with VKH experienced severe blood sugar spikes and pituitary gland changes after receiving steroid treatment but had no prior health issues.
- Following treatment and management of his hyperglycemia, imaging showed noticeable regeneration of the photoreceptor layer, suggesting possible recovery after inflammation subsides.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!